Maha Mian, PhD

Title(s)Postdoctoral Scholar, Psychiatry
SchoolSchool of Medicine
Address280 West MacArthur Blvd
Oakland 94611
ORCID ORCID Icon0000-0001-7051-7820 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    VA Palo Alto HCSClinical Internship08/2022Clinical Psychology
    University at Albany, SUNYPhD08/2022Clinical Psychology
    University at Albany, SUNYMA12/2019Psychology
    Tufts UniversityBS05/2014Biopsychology

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Development of the Protective Strategies for Psychedelics Scale: A novel inventory to assess safety strategies in the context of psychedelics. J Psychopharmacol. 2024 Jan; 38(1):101-109. Mian MN, Altman BR, Low F, Earleywine M. PMID: 38050326; PMCID: PMC10851634.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    2. Cannabis Use Among U.S. Military Veterans Following Residential Substance Use Disorder Treatment. Mil Med. 2023 11 03; 188(11-12):e3591-e3598. Mian MN, Chan Osilla K, Blonigen D. PMID: 37294846; PMCID: PMC10629989.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    3. Exploring preferences for different modes of cannabis use during early pregnancy: A qualitative study. Addict Behav. 2023 11; 146:107812. Mian MN, Foti TR, Green A, Iturralde E, Altschuler A, Does MB, Jackson-Morris M, Adams SR, Satre DD, Ansley D, Young-Wolff KC. PMID: 37490827.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    4. Savoring as an intervention for cannabis use: acceptability, feasibility, and preliminary results. Addiction Research & Theory. 2022. Mian, Maha N. Earleywine, Mitch.
    5. Perceptions About Cannabis Following Legalization Among Pregnant Individuals With Prenatal Cannabis Use in California. JAMA Netw Open. 2022 12 01; 5(12):e2246912. Young-Wolff KC, Foti TR, Green A, Altschuler A, Does MB, Jackson-Morris M, Adams SR, Ansley D, Conway A, Goler N, Mian MN, Iturralde E. PMID: 36515947; PMCID: PMC9856570.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    6. Policing Pot: State-Level Cannabis Arrests Increase Perceived Risks and Costs but Not Use. Cannabis. 2022; 5(2):40-49. Mian MN, Vogel M, Altman BR, Ueno LF, Earleywine M. PMID: 37287955; PMCID: PMC10212252.
      View in: PubMed   Mentions:
    7. Cannabis's Link to Schizotypy: Phenomenon, Measurement Bias, or Delusion? Cannabis. 2022; 5(2):28-39. Altman BR, Earleywine M, Mian MN, Dalal DK. PMID: 37287953; PMCID: PMC10212240.
      View in: PubMed   Mentions:
    8. Expectancies for Cannabis- Induced Emotional Breakthrough, Mystical Experiences and Changes in Dysfunctional Attitudes: Perceptions of the Potential for Cannabis-Assisted Psychotherapy for Depression. Cannabis. 2022; 5(2):16-27. Earleywine M, Mian MN, Altman BR, De Leo JA. PMID: 37287954; PMCID: PMC10212245.
      View in: PubMed   Mentions:
    9. Policing Pot: State-Level Cannabis Arrests Increase Perceived Risks and Costs but Not Use. Cannabis. 2022; 2(5):40-49. Mian MN Vogel M Altman BR Ueno, LF Earleywine M.
    10. Cannabis’s Link to Schizotypy: Phenomenon, Measurement Bias, or Delusion?. Cannabis. 2022; 2(5):28-39. Altman BR Earleywine M Mian MN Dalal D.
    11. Expectancies for Cannabis-Induced Emotional Breakthrough, Mystical Experiences and Changes in Dysfunctional Attitudes: Perceptions of the Potential for Cannabis-Assisted Psychotherapy for Depression. Cannabis. 2022; 2(5):16-27. Earleywine M Mian MN Altman BR De Leo J.
    12. Expectancies about the effects of cannabidiol products on anxiety symptoms. Journal of Substance Use. 2021. Altman BR Mian MN Ueno LF Earleywine M.
    13. Packing cannabis, pouring alcohol: Validating a free-pack assessment among college students using cannabis. Psychol Addict Behav. 2021 Dec; 35(8):877-886. Mian MN, Altman BR, Morrissey C, Ueno LF, Dalal D, Earleywine M. PMID: 33793281.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    14. Cannabis-induced oceanic boundlessness. J Psychopharmacol. 2021 Jul; 35(7):841-847. Earleywine M, Ueno LF, Mian MN, Altman BR. PMID: 33779383.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    15. Factor analysis of a short form of the Protective Behavioral Strategies for Marijuana scale. Addict Behav. 2021 06; 117:106852. Mian MN, Altman BR, Luba R, Ueno LF, Dalal D, Earleywine M. PMID: 33581678; PMCID: PMC8459399.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    16. Age-Related Differences in Cannabis Product Use. J Psychoactive Drugs. 2021 Sep-Oct; 53(4):312-318. Ueno LF, Mian MN, Altman BR, Giandelone E, Luce M, Earleywine M. PMID: 33432879.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    17. Symptom specificity of ayahuasca’s antidepressant effects. Journal of Psychedelic Drugs. 2021. Gilbert C Earleywine M Mian MN Altman BR.
    18. Confirming Savoring's Link to Fewer Cannabis Problems. J Psychoactive Drugs. 2021 Jul-Aug; 53(3):201-206. Mian MN, Altman BR, Ueno LF, Earleywine M. PMID: 33225860.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    19. Gender-based differential item functioning in the Cannabis-Associated Problems Questionnaire: A replication and extension. Addict Behav. 2021 01; 112:106658. Altman BR, Mian MN, Dalal D, Ueno LF, Luba R, Slavin MN, Earleywine M. PMID: 32987304; PMCID: PMC7810355.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    20. Examining and validating the factor structure of the Cannabis-Associated Problems Questionnaire. Journal of Substance Use. 2020. Altman BR Mian MN Ueno LF Earleywine M.
    21. Establishing safety and stability for enhanced treatment engagement with the Unified Protocol. Clinical Case Studies. 2020; 6(19):473-490. Mian MN, Lin B, Hormes JM, Earleywine M.
    22. The Novelty of Ayahuasca Scale and the prediction of intentions to use. Journal of Psychedelic Drugs. 2020; 2(4):93-103. Altman BR Mian MN Earleywine M.
    23. Ayahuasca's Antidepressant Effects Covary with Behavioral Activation as Well as Mindfulness. J Psychoactive Drugs. 2020 Apr-Jun; 52(2):130-137. Mian MN, Altman BR, Earleywine M. PMID: 31570056.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    24. Cannabis Expectancies for Sleep. J Psychoactive Drugs. 2019 Nov-Dec; 51(5):405-412. Altman BR, Mian MN, Slavin M, Earleywine M. PMID: 31319769; PMCID: PMC10446891.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    25. Who Volunteers for Cannabis Research? Examining potential participation in cannabis research among emerging adults. Cannabis. 2019; 2(2):135-143. Mian MN Altman BR Earleywine M .
    26. The Role of Impulsivity and Expectancies in Predicting Marijuana Use: An Application of the Acquired Preparedness Model. J Psychoactive Drugs. 2018 Nov-Dec; 50(5):411-419. Luba R, Earleywine M, Farmer S, Slavin M, Mian M, Altman B. PMID: 30183528.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    27. Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamine. Psychopharmacology (Berl). 2018 05; 235(5):1371-1387. Fischer KD, Houston ACW, Desai RI, Doyle MR, Bergman J, Mian M, Mannix R, Sulzer DL, Choi SJ, Mosharov EV, Hodgson NW, Bechtholt A, Miczek KA, Rosenberg PA. PMID: 29468294; PMCID: PMC5999338.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    28. Shaken Baby Syndrome: a review. Fetal Pediatr Pathol. 2015 Jun; 34(3):169-75. Mian M, Shah J, Dalpiaz A, Schwamb R, Miao Y, Warren K, Khan S. PMID: 25616019.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    Maha's Networks
    Concepts (73)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (2)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.